Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: An insight into the APC-resistance assay

Blood

Volumn 87, Issue 11, 1996, Pages 4695-4707

  Kalafatis, Michael ^b   Haley, Paul E ^b   Lu, Deshun ^b   Bertina, Rogier M ^b   Long, George L ^b   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING; ENZYME ACTIVITY; ENZYME INACTIVATION; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0029953827     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4695.bloodjournal87114695     Document Type: Article

References (30)

1. Mann KG, Jenny RJ, Krishnaswamy S: Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915, 1988
2. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S: Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76:1, 1990
3. Nesheim ME, Taswell JB, Mann KG: The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 254:10952, 1979
4. Kane WH, Davie EW: Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci USA 83:6800, 1986
5. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846, 1987
6. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
8. Sun X, Evatt B, Griffin JH: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83:3120, 1994
9. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84:1031, 1994
10. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504, 1995
11. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994
12. R506Q. J Biol Chem 270:4053, 1995
13. Barenholz Y, Gibbs D, Litmann BJ, Goll J, Thompson T, Carlson D: A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 16:2806, 1977
14. Foster BW, Tucker MM, Katzmann JA, Miller RS, Nesheim ME, Mann KG: Monoclonal antibodies to human coagulation factor V and factor Va. Blood 61:1060, 1983
15. Bajaj SP, Rapaport SI, Prodanos C: A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 11:397, 1981
16. Kisiel W, Davie EW: Protein C. Methods Enzymol 80:320, 1981
17. 34 → Met). J Biol Chem 269:29032, 1994
18. Laemmli UK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680, 1970
19. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 76:4350, 1979
20. Kalafatis M, Lu D, Bertina RM, Long GL, Mann KG: Biochemical prototype for familial thrombosis. A study combining a functional protein C mutation and factor V Leiden. Arterioscler Thromb Vasc Biol 15:2181, 1995
21. Nesheim ME, Katzmann JA, Tracy PB, Mann KG: Factor V. Methods Enzymol 80:249, 1981
22. Vermont. Blood 84:687, 1994
23. Jackson DE, Mitchell CA, Salem HH: Protein C is responsible for the rapid inactivation of factor Va following blood clotting in vitro. Thromb Haemost 72:70, 1994
24. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503, 1993
25. 506 of factor V. Lancet 343:1535, 1994
26. The Le D, Griffin JH, Greengard JS, Mujumdar V, Rapaport SI: Use of a generally applicable tissue factor-dependent factor V assay to detect activated protein C resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood 85:1704, 1995
27. Bakker HM, Tans G, Thomassen MCLGD, Yukelson LY, Ebberink R, Hemker HC, Rosing J: Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain. J Biol Chem 269:20662, 1994
28. Lawson JH, Kalafatis M, Stram S, Mann KG: A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357, 1994
29. Jones KC, Mann KG: A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem 269:23367, 1994
30. R506Q by activated protein C. J Biol Chem 270:21158, 1995